# Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/optimal-dose-of-lisinopril-for-renoprotection-in-type-1-diabetic-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | K. J. Schjoedt,Anne Sofie Astrup,Frederik Persson,Erik Frandsen,Frans Boomsma,Kasper Rossing,Lise Tarnow,Peter Rossing,H.‐H. Parving |
| Citations | 37 |
| DOI | 10.1007/s00125-008-1184-8 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://link.springer.com/content/pdf/10.1007/s00125-008-1184-8.pdf |
| OpenAlex ID | https://openalex.org/W1997402884 |
| PMID | 18974967 |
| Type | article |
| Year | 2008 |

## Paper authors

- [K. J. Schjoedt](https://scholariq.org/researchers/k-j-schjoedt/)

## Paper journal

- [Diabetologia](https://scholariq.org/journals/diabetologia/)

## Paper primary topic

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Paper topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.